Birdwatch Note Rating
2024-06-16 21:11:51 UTC - NOT_HELPFUL
Rated by Participant: 2DED4DDADC5B81EAD455FF459711EC15B3F5A592DB15A1ADB80C70D407706A1C
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 53% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://www.nejm.org/doi/full/10.1056/nejmoa1910993 https://www.paho.org/en/topics/ebola-virus-disease
All Note Details